From: ExI Office (exi-info@extropy.org)
Date: Wed Mar 08 2000 - 04:01:27 MST
>Delivered-To: maxmore-max@maxmore.com
>From: "promotions@liebertpub.com" <promotions@liebertpub.com>
>Date: Tue, 07 Mar 2000 20:27:39 "GMT"
>X-mailer: AspMail 3.03 (SMTP656391)
>Subject: e-biomed: the journal of regenerative medicine Lauches,
>Exclusively Online
>X-MIME-Autoconverted: from quoted-printable to 8bit by
>emu.prod.itd.earthlink.net id NAA27692
>
>For Immediate Release
>
>Contact: Christopher Dauer (914) 834-3100, ext. 613; cdauer@liebertpub.com
>
>e-biomed: the journal of regenerative medicine
> Launches, Exclusively Online
>
>March 7, 2000 Larchmont, NY A new peer-reviewed electronic journal
>entitled e-biomed: the journal of regenerative medicine has been
>published, focusing on a unique approach to healing—the regeneration of
>organs, tissues, and cells. To facilitate advances in this exciting new
>field, “papers will be published electronically, immediately upon
>acceptance,” said Mary Ann Liebert, president of Mary Ann Liebert, Inc.
>(www.liebertpub.com.) Connect to www.liebertpub.com/reg to view, at no
>cost, the first 8 papers.
>
>“The implications of renewing body tissues with the help of natural
>signals that control its growth are enormous,” said the Journal’s
>editor-in-chief, William A. Haseltine, Ph.D., who has coined the term
>“regenerative medicine” to signify this promising area of research
>endeavor. “As we understand the body’s repair process at the genetic
>level,” Dr. Haseltine said, “we will be able to advance the goal of
>maintaining our bodies in normal function, perhaps perpetually.” Dr.
>Haseltine is the Chairman and CEO of Human Genome Sciences, a Maryland
>biotechnology company (NASDAQ: HGSI).
>
>The Journal has an outstanding and diverse editorial board of 100 leaders
>in different disciplines, including Robert Langer, W. French Anderson,
>Jeffrey Isner, R. Michael Blaese, Judith Campisi, and Gary Nabel.
>
>The inaugural issue includes papers on Tissue Engineering: Status and
>Challenges; Transplantation Therapies from Human Embryonic Stem
>Cell—Circumventing Immune Rejection; and Regenerative Biology of Hearing:
>Taking the Breaks Off the Cell Cycle Engine.
>
>The manuscript submission and peer-review process of the Journal is
>strictly electronic, with papers available on-line to subscribers within
>three weeks of acceptance. Enrollees in Liebert Alert, the free table of
>contents alerting service, will automatically be sent an e-mail
>notification that a new article has been published. The on-line Journal
>is available in a variety of formats, including PDF, for use with Adobe
>Reader. Papers are fully searchable by key word or phrase, plain text,
>abstract only, etc. The reference citations are hyperlinked to external
>resources on the Internet such as Medline and IFI’s Web of Science.
>
>Mary Ann Liebert, Inc. is an independent publisher of cutting-edge
>biomedical journals, books and newsletters, with leading publications
>including Genetic Engineering News, Human Gene Therapy, Cloning,
>Microbial & Comparative Genomics, Tissue Engineering, and many more.
>
>For more information or to subscribe to e-biomed, visit www.liebertpub.com/reg
This archive was generated by hypermail 2.1.5 : Fri Nov 01 2002 - 15:27:15 MST